IM Cannabis Corp. Raises C$5.62M in Private Placement

Ticker: IMCC · Form: 6-K · Filed: 2025-07-31T00:00:00.000Z

Sentiment: neutral

Topics: private-placement, financing, capital-raise

TL;DR

IM Cannabis Corp. just closed a C$5.62M private placement at C$2.74/unit.

AI Summary

On July 30, 2025, IM Cannabis Corp. entered into subscription agreements for a private placement financing. The company will issue 2,050,000 units at C$2.74 per unit to certain investors, raising gross proceeds of approximately C$5.62 million.

Why It Matters

This private placement provides IM Cannabis Corp. with additional capital, which can be used for operational expansion or strategic initiatives, potentially strengthening its market position.

Risk Assessment

Risk Level: medium — Private placements can be subject to market volatility and may indicate a need for capital, but the specific terms and use of funds will determine the ultimate impact.

Key Numbers

C$5.62M — Gross Proceeds (Raised from the private placement offering on July 30, 2025.)
2,050,000 — Units Sold (Number of units issued in the private placement.)
C$2.74 — Price Per Unit (The price at which each unit was sold in the private placement.)

Key Players & Entities

IM Cannabis Corp. (company) — Registrant
July 30, 2025 (date) — Date of subscription agreements
2,050,000 (number) — Number of units to be sold
C$2.74 (dollar_amount) — Purchase price per unit
C$5.62 million (dollar_amount) — Gross proceeds from the offering

FAQ

What is the total amount IM Cannabis Corp. expects to raise from this private placement?

IM Cannabis Corp. expects to raise approximately C$5.62 million in gross proceeds from the private placement.

On what date were the subscription agreements for the private placement entered into?

The subscription agreements were entered into on July 30, 2025.

How many units will be issued in this private placement?

A total of 2,050,000 units will be issued in this private placement.

What is the purchase price per unit for this private placement?

The purchase price per unit is C$2.74.

Who are the investors in this private placement?

The filing states that the private placement is with 'certain investors' but does not name them specifically.

From the Filing

0001178913-25-002563.txt : 20250731 0001178913-25-002563.hdr.sgml : 20250731 20250731172714 ACCESSION NUMBER: 0001178913-25-002563 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 8 CONFORMED PERIOD OF REPORT: 20250731 FILED AS OF DATE: 20250731 DATE AS OF CHANGE: 20250731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IM Cannabis Corp. CENTRAL INDEX KEY: 0001792030 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40065 FILM NUMBER: 251172843 BUSINESS ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 BUSINESS PHONE: 416-256-4202 MAIL ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 6-K 1 zk2533508.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of July 2025 (Report No. 4) .   Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executive offices)   Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒  Form 40-F ☐   CONTENTS Private Placement Offering   On July 30, 2025, IM Cannabis Corp. (the “ Company ”) entered into subscription agreements (the “ Subscription Agreements ”) for a private placement financing with certain investors (the “Offering”). Under the Subscription Agreements, the investors have agreed to purchase an aggregate of 2,050,000 units (each a “Unit”, and collectively, the “ Units ”) at a purchase price of C$2.74 per Unit. Each Unit consists of one common share of the Company, no par value per share (the “ Common Shares ”), or one common share pre-funded warrant in lieu thereof (the “ Pre-Funded Warrants ”), and one common share purchase warrant (the “ Warrants ”).   The Offering amount and Unit price were calculated based on the official exchange rate as of July 21, 2025, of 1 USD = 1.3713 CAD (USD/ILS = 3.3550; CAD/ILS = 2.4465) as published on the website of the Bank of Israel (the “ Exchange Rate ”).   Each Warrant entitles its holder to purchase one Common Share (each, a “ Warrant Share ”) at an exercise price of C$3.43 per Warrant Share, became exercisable immediately upon issuance and for a period of sixty (60) months from its issuance. If the Warrants are not exercised by the applicable expiry date, the Warrants will expire and be of no further force or effect. The Warrants and the Warrant Shares may not be traded for a period of four (4) months, unless permitted under applicable securities legislation.   Each Pre-Funded Warrant entitles its holder to purchase one Common Share (each, a “ Pre-Funded Share ”) at a price of C$0.00001 per Pre-Funded Share, became exercisable immediately upon issuance and may be exercised at any time until exercised in full. The Pre-Funded Warrants and the Pre-Funded Warrant Shares may not be traded for a period of four (4) months, unless permitted under applicable securities legislation.   The Offering resulted in gross proceeds to the Company of C$5,622,522, which the Company intends to use for general working capital, repayment of existing indebtedness and general corporate purposes. The Offering closed on July 30, 2025.   Pursuant to the Subscription Agreement, the Company has agreed to file a resale registration statement on Form F-3 (or other available form) (the “ Registration Statement ”) providing for the resale by the purchasers of th